1-2 of 2
Kathleen Large
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Updates from Ongoing, First-in-Human Phase 1 Dose Escalation and Expansion Study of TTI-621, a Novel Biologic Targeting CD47, in Patients with Relapsed or Refractory Hematologic Malignancies

Steven M. Horwitz, James M. Foran, Michael Maris, Jennifer Kimberly Lue, Ahmed Sawas, Craig Okada, Tatyana A. Feldman, Lubomir Sokol, Matthew Mei, Ian W. Flinn, Diego Villa, Mary-Elizabeth M. Percival, Deepa Jagadeesh, Kerry J. Savage, Oleg Akilov, Catherine S. Diefenbach, Youn H. Kim, Gloria H. Y. Lin, Tina Catalano, Penka S. Petrova, Bob Uger, Naomi Molloy, Kathleen Large, Ingmar Bruns, Stephen M. Ansell
Journal: Blood
Blood (2021) 138 (Supplement 1): 2448.
https://doi.org/10.1182/blood-2021-154490
Published: 2021
Journal Articles

Updates from Ongoing, First-in-Human Phase 1 Dose Escalation and Expansion Study of TTI-621, a Novel Biologic Targeting CD47, in Patients with Relapsed or Refractory Hematologic Malignancies

Steven M. Horwitz, MD, James M. Foran, MD, Michael Maris, MD, Ahmed Sawas, MD, Craig Okada, MD PhD, Tatyana A. Feldman, MD, Mark D. Minden, Lubomir Sokol, MD PhD, Matthew Mei, MD, Ian W. Flinn, MD PhD, Diego Villa, MDMPH, Mary-Elizabeth M. Percival, MD, Deepa Jagadeesh, MDMPH, Kerry J. Savage, MDMSc, Oleg E. Akilov, MD PhD, Catherine Diefenbach, MD, Youn H. Kim, MD, Gloria H. Y. Lin, PhD, Tina Catalano, MSc, Penka S. Petrova, PhD, Bob Uger, PhD, Naomi Molloy, BSc, Kathleen Large, RN, MSN, Yaping Shou, MDPhD, Stephen M. Ansell, MD PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 41–43.
https://doi.org/10.1182/blood-2020-136198
Published: 2020